CASI Pharmaceuticals (CASI) Reports Q1 Loss of $0.06/Share

CASI Pharmaceuticals (NASDAQ: CASI) reported Q1 EPS of ($0.06), versus ($0.05) reported last year. Revenue for the quarter came in at $23.7 thousand, versus $0 reported last year.

For earnings history and earnings-related data on CASI Pharmaceuticals (CASI) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• TD Cowen Upgrades Flagstar Bank (FLG) to Buy
• Jefferies Upgrades Yihai International Holding Ltd. (1579:HK) (YNNHF) to Buy